Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5476
Protalix BioTherapeutics
PLX
$193M
| $545K | ﹤0.01% |
251,345
-11,464
| -4% | -$28.4K |
|
5477
Taylor Devices
TAYD
$178M
| $545K | ﹤0.01% |
+9,556
| New | +$735K |
|
5478
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$16.6M
| $545K | ﹤0.01% |
+18,390
| New | +$519K |
|
5479
Calamos Strategic Total Return Fund
CSQ
$3.21B
| $542K | ﹤0.01% |
31,646
| – | – |
|
5480
CALL
GE HealthCare
GEHC
$27.8B
| $541K | ﹤0.01% |
7,600
-132,400
| -95% | -$10.4M |
|
5481
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$545M
| $540K | ﹤0.01% |
+9,057
| New | +$579K |
|
|
AKTS
5482
Aktis Oncology
AKTS
$1.34B
| $540K | ﹤0.01% |
+30,163
| New | +$586K |
|
5483
Owlet
OWLT
$152M
| $540K | ﹤0.01% |
104,966
-5,648
| -5% | -$59.8K |
|
5484
Bally's
BALY
$686M
| $536K | ﹤0.01% |
55,651
+793
| +1% | +$11.3K |
|
5485
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$704M
| $536K | ﹤0.01% |
+11,618
| New | +$592K |
|
5486
Crexendo
CXDO
$224M
| $536K | ﹤0.01% |
86,836
-7,482
| -8% | -$49.1K |
|
5487
AirSculpt Technologies
AIRS
$331M
| $535K | ﹤0.01% |
189,022
+73,854
| +64% | +$172K |
|
|
PALD
5488
Direxion Daily PANW Bear 1X ETF
PALD
$2.49M
| $533K | ﹤0.01% |
20,000
| – | – |
|
5489
Microvision
MVIS
$88.8M
| $533K | ﹤0.01% |
830,620
+453,672
| +120% | +$346K |
|
5490
Xtrackers Net Zero Pathway Paris Aligned US Equity ETF
USNZ
$287M
| $531K | ﹤0.01% |
13,199
-12,297
| -48% | -$523K |
|
5491
vTv Therapeutics
VTVT
$122M
| $529K | ﹤0.01% |
13,350
+7,819
| +141% | +$284K |
|
5492
Global Water Resources
GWRS
$211M
| $529K | ﹤0.01% |
69,687
+14,956
| +27% | +$126K |
|
5493
CALL
Caesars Entertainment
CZR
$6.1B
| $529K | ﹤0.01% |
+20,000
| New | +$476K |
|
5494
TTEC Holdings
TTEC
$107M
| $529K | ﹤0.01% |
211,436
+102,024
| +93% | +$292K |
|
5495
POET Technologies
POET
$1.22B
| $528K | ﹤0.01% |
88,972
-204,691
| -70% | -$1.33M |
|
|
XMAX
5496
XMAX Inc
XMAX
$537M
| $528K | ﹤0.01% |
72,962
-46,526
| -39% | -$289K |
|
5497
ECB Bancorp
ECBK
$179M
| $520K | ﹤0.01% |
31,079
+10,356
| +50% | +$179K |
|
5498
Treace Medical Concepts
TMCI
$265M
| $519K | ﹤0.01% |
387,685
+198,833
| +105% | +$396K |
|
5499
American Century Focused Dynamic Growth ETF
FDG
$386M
| $517K | ﹤0.01% |
+4,533
| New | +$551K |
|
5500
Lifezone Metals
LZM
$302M
| $517K | ﹤0.01% |
153,865
+119,366
| +346% | +$554K |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.